Retrospective study of adjuvant chemotherapy effects on survival rate after three-field lymph node dissection for stage IIA esophageal cancer

2Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

To determine the efficacy of postoperative adjuvant chemotherapy with paclitaxel plus cisplatin (Taxol + DDP, TP therapy) for stage IIA esophageal squamous cell carcinoma (ESCC) and to investigate the expression of RUNX3 in lymph node metastasis-negative esophageal cancer and its relationship with medical prognosis, a retrospective summary of clinical treatment of 143 cases of stage IIA esophageal squamous cell carcinoma patients was made. The patients were divided into two groups, a surgery alone control group (52 patients) and a chemotherapy group that received postoperative TP therapy (91 patients). The disease-free and 5 year survival rates were compared between the groups and a multivariate analysis of prognostic factors was performed. The same analysis was performed for cases classified as RUNX3 positive and negative, with post-operative specimens assessed by immunohistochemistry. Although the disease-free and 5 year survival rates in control and chemotherapy groups did not significantly differ and there was no significance in RUNX3 negative cases, postoperative adjuvant chemotherapy in the chemotherapy group was shown to improve disease-free and 5 year survival rate compared to the control group in RUNX3 positive cases. On Cox regression multivariate analysis, postoperative adjuvant chemotherapy (P<0.01) was an independent prognostic factor for RUNX3 positive cases, suggesting that postoperative TP may be effective as adjuvant chemotherapy for stage IIA esophageal cancer patients with RUNX3 positive lesions.

References Powered by Scopus

Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study - JCOG9204

642Citations
N/AReaders
Get full text

Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities

431Citations
N/AReaders
Get full text

RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization

211Citations
N/AReaders
Get full text

Cited by Powered by Scopus

5-Azacytidine suppresses EC9706 cell proliferation and metastasis by upregulating the expression of SOX17 and CDH1

11Citations
N/AReaders
Get full text

Prognostic significance of the T2 substage in patients with esophageal squamous cell carcinoma

3Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Chen, H. X., & Wang, Z. (2015). Retrospective study of adjuvant chemotherapy effects on survival rate after three-field lymph node dissection for stage IIA esophageal cancer. Asian Pacific Journal of Cancer Prevention, 16(13), 5169–5173. https://doi.org/10.7314/APJCP.2015.16.13.5169

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

80%

Professor / Associate Prof. 1

20%

Readers' Discipline

Tooltip

Medicine and Dentistry 6

75%

Biochemistry, Genetics and Molecular Bi... 1

13%

Economics, Econometrics and Finance 1

13%

Save time finding and organizing research with Mendeley

Sign up for free